Neuland Laboratories Limited
NSE:NEULANDLAB.NS
15590.2 (INR) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3,108.438 | 4,396.017 | 3,850.097 | 3,928.283 | 4,177.486 | 3,629.939 | 4,070.726 | 2,692.5 | 2,937.055 | 2,211.699 | 2,300.989 | 2,364.698 | 2,578.476 | 2,008.867 | 2,320.568 | 2,453.918 | 2,413.928 | 2,054.238 | 1,866.793 | 2,038.437 | 1,862.177 | 1,810.075 | 1,518.024 | 1,714.795 | 1,687.408 | 1,539.575 | 1,475.077 | 1,413.644 | 1,444.289 | 1,450.067 |
Cost of Revenue
| 1,597.557 | 3,024.552 | 2,589.713 | 1,785.915 | 1,915.805 | 1,836.048 | 2,086.589 | 1,394.345 | 1,462.023 | 1,194.896 | 1,499.707 | 1,399.942 | 1,467.164 | 1,168.178 | 1,435.743 | 1,426.569 | 1,478.994 | 1,245.677 | 1,144.15 | 1,295.989 | 1,139.809 | 1,197.899 | 1,113.486 | 1,127.507 | 1,141.237 | 1,049.333 | 825.99 | 749.544 | 909.049 | 880.123 |
Gross Profit
| 1,510.881 | 1,371.465 | 1,260.384 | 2,142.368 | 2,261.681 | 1,793.891 | 1,984.137 | 1,298.155 | 1,475.032 | 1,016.803 | 801.282 | 964.756 | 1,111.312 | 840.689 | 884.825 | 1,027.349 | 934.934 | 808.561 | 722.643 | 742.448 | 722.368 | 612.176 | 404.538 | 587.288 | 546.171 | 490.242 | 649.087 | 664.1 | 535.24 | 569.944 |
Gross Profit Ratio
| 0.486 | 0.312 | 0.327 | 0.545 | 0.541 | 0.494 | 0.487 | 0.482 | 0.502 | 0.46 | 0.348 | 0.408 | 0.431 | 0.418 | 0.381 | 0.419 | 0.387 | 0.394 | 0.387 | 0.364 | 0.388 | 0.338 | 0.266 | 0.342 | 0.324 | 0.318 | 0.44 | 0.47 | 0.371 | 0.393 |
Reseach & Development Expenses
| 0 | 0 | 349.917 | 0 | 0 | 0 | 277.576 | 0 | 0 | 0 | 277.23 | 0 | 0 | 0 | 210.658 | 0 | 0 | 0 | 174.114 | 0 | 0 | 0 | 166.321 | 0 | 0 | 0 | 49.884 | 69.638 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -60.687 | 235.948 | 155.922 | 161.269 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 227.438 | 62.114 | 71.432 | 111.326 |
SG&A
| 0 | 300.666 | 355.844 | 272.447 | 197.221 | 598.885 | 290.255 | 241.089 | 258.742 | 482.997 | 446.828 | 480.367 | 473.374 | 152.513 | 321.927 | 379.019 | 337.792 | 346.315 | 336.75 | 310.283 | 299.048 | 296.226 | 310.361 | 285.98 | 262.655 | 271.108 | 166.751 | 298.062 | 227.354 | 272.595 |
Other Expenses
| 1,510.881 | 0 | 53.57 | 21.006 | 30.478 | 20.389 | 80.642 | 9.331 | 2.391 | 5.118 | -31.607 | 19.001 | 2.864 | 20.559 | -1.635 | 1.953 | 6.059 | 6.974 | -7.765 | 10.224 | 5.696 | 5.177 | -11.615 | 4.053 | 6.385 | 11.137 | 0 | 0 | 0 | 0 |
Operating Expenses
| 1,510.881 | 300.666 | 355.844 | 1,081.151 | 1,031.886 | 960.547 | 920.256 | 890.686 | 913.783 | 858.749 | 490.067 | 768.18 | 802.765 | 702.087 | 716.703 | 665.432 | 619.014 | 558.745 | 480.894 | 539.029 | 555.694 | 501.081 | 235.946 | 501.217 | 457.334 | 455.487 | 364.198 | 555.415 | 329.101 | 363.432 |
Operating Income
| 0 | 1,070.799 | 904.54 | 1,082.223 | 1,260.273 | 833.344 | 1,144.523 | 416.8 | 563.64 | 158.054 | 317.207 | 196.576 | 308.517 | 138.602 | 168.122 | 361.917 | 315.92 | 249.816 | 241.749 | 203.419 | 166.674 | 111.095 | 168.592 | 86.071 | 88.837 | 34.755 | 323.167 | 150.121 | 206.693 | 204.355 |
Operating Income Ratio
| 0 | 0.244 | 0.235 | 0.275 | 0.302 | 0.23 | 0.281 | 0.155 | 0.192 | 0.071 | 0.138 | 0.083 | 0.12 | 0.069 | 0.072 | 0.147 | 0.131 | 0.122 | 0.129 | 0.1 | 0.09 | 0.061 | 0.111 | 0.05 | 0.053 | 0.023 | 0.219 | 0.106 | 0.143 | 0.141 |
Total Other Income Expenses Net
| 494.226 | 227.621 | 17.48 | -16.407 | -13.855 | -1.749 | -42.887 | -18.118 | -29.363 | -23.463 | -74.454 | -14.217 | -32.736 | -17.87 | -155.715 | -42.44 | -29.064 | -46.714 | -82.919 | -46.701 | -42.132 | -35.11 | -93.106 | -25.946 | -34.353 | -27.699 | -48.31 | -52.937 | -52.796 | -54.447 |
Income Before Tax
| 494.226 | 1,298.42 | 922.02 | 1,044.81 | 1,215.94 | 831.595 | 1,101.636 | 389.351 | 531.886 | 134.591 | 242.753 | 182.359 | 275.781 | 120.732 | 243.901 | 319.477 | 286.856 | 203.102 | 171.98 | 156.718 | 124.542 | 75.985 | 81.705 | 60.125 | 54.484 | 7.056 | 274.858 | 97.185 | 153.897 | 149.908 |
Income Before Tax Ratio
| 0.159 | 0.295 | 0.239 | 0.266 | 0.291 | 0.229 | 0.271 | 0.145 | 0.181 | 0.061 | 0.105 | 0.077 | 0.107 | 0.06 | 0.105 | 0.13 | 0.119 | 0.099 | 0.092 | 0.077 | 0.067 | 0.042 | 0.054 | 0.035 | 0.032 | 0.005 | 0.186 | 0.069 | 0.107 | 0.103 |
Income Tax Expense
| 165.799 | 319.693 | 246.401 | 230.908 | 323.462 | 212.805 | 256.197 | 83.869 | 147.289 | 34.933 | 24.945 | 53.003 | 72.07 | 33.387 | 70.975 | 52.125 | 72.456 | 51.472 | 264.937 | 45.614 | 37.655 | 18.914 | 15.399 | 13.209 | 8.974 | 1.375 | 70.727 | 33.67 | 50.01 | 49.408 |
Net Income
| 328.427 | 978.727 | 675.619 | 813.902 | 892.478 | 618.79 | 845.439 | 305.482 | 384.597 | 99.658 | 217.807 | 129.356 | 203.711 | 87.345 | 172.926 | 267.352 | 214.4 | 151.63 | -92.957 | 111.104 | 86.887 | 57.071 | 66.306 | 46.916 | 45.51 | 5.681 | 204.131 | 63.515 | 103.887 | 100.5 |
Net Income Ratio
| 0.106 | 0.223 | 0.175 | 0.207 | 0.214 | 0.17 | 0.208 | 0.113 | 0.131 | 0.045 | 0.095 | 0.055 | 0.079 | 0.043 | 0.075 | 0.109 | 0.089 | 0.074 | -0.05 | 0.055 | 0.047 | 0.032 | 0.044 | 0.027 | 0.027 | 0.004 | 0.138 | 0.045 | 0.072 | 0.069 |
EPS
| 25.6 | 76.28 | 52.66 | 63.44 | 69.56 | 48.23 | 65.9 | 23.81 | 29.98 | 7.77 | 16.98 | 10.08 | 15.88 | 6.81 | 13.48 | 20.84 | 16.71 | 11.82 | -7.25 | 8.66 | 6.77 | 4.45 | 5.17 | 3.66 | 3.55 | 0.44 | 22.98 | 7.15 | 11.69 | 11.31 |
EPS Diluted
| 25.6 | 76.28 | 52.66 | 63.44 | 69.56 | 48.23 | 65.9 | 23.81 | 29.97 | 7.77 | 16.97 | 10.08 | 15.88 | 6.81 | 13.48 | 20.84 | 16.71 | 11.82 | -7.24 | 8.66 | 6.77 | 4.45 | 5.17 | 3.66 | 3.55 | 0.44 | 22.98 | 7.15 | 11.69 | 11.31 |
EBITDA
| 665.602 | 1,487.924 | 1,122.736 | 1,233.661 | 1,405.35 | 989.591 | 1,279.222 | 550.163 | 695.359 | 291.165 | 394.996 | 343.325 | 431.207 | 277.449 | 401.101 | 467.954 | 414.675 | 345.414 | 318.935 | 291.825 | 255.189 | 191.812 | 140.568 | 163.657 | 154.392 | 102.499 | 369.901 | 188.687 | 245.259 | 242.92 |
EBITDA Ratio
| 0.214 | 0.338 | 0.278 | 0.314 | 0.336 | 0.273 | 0.314 | 0.204 | 0.237 | 0.132 | 0.154 | 0.145 | 0.167 | 0.138 | 0.147 | 0.191 | 0.172 | 0.168 | 0.142 | 0.143 | 0.137 | 0.106 | 0.093 | 0.095 | 0.091 | 0.067 | 0.251 | 0.133 | 0.17 | 0.168 |